Halcion (Triazolam)

Halcion (triazolam) is indicated for the short‑term treatment of insomnia when rapid onset of sleep is desired.

• Initiation of sleep in adults with transient insomnia.
• Management of difficulty maintaining sleep for up to a few nights.
• Use in patients who require a short‑acting hypnotic for procedural sedation (off‑label in some regions).
• Adjunct therapy for sleep disturbances associated with psychiatric conditions, under specialist supervision.

Side effects of Halcion vary in frequency and severity; they are categorized as common or serious.

Common

• Drowsiness or excessive sedation.
• Dizziness or light‑headed feeling.
• Headache.
• Anterograde amnesia affecting memory of events after taking the medication.
• Impaired coordination or balance.
• Altered taste perception.

Serious

• Respiratory depression, especially when combined with other depressants.
• Severe allergic reactions such as rash, itching, or swelling.
• Paradoxical agitation, aggression, or anxiety.
• Depression or emergence of suicidal thoughts.
• Physical dependence and withdrawal syndrome upon abrupt discontinuation.

When prescribing Halcion, clinicians consider several precautions to minimize risks and ensure safe use.

• Limit use to short durations, typically no longer than two weeks.
• Assess for a personal or family history of substance abuse or dependence.
• Avoid in patients with severe respiratory insufficiency or chronic obstructive pulmonary disease.
• Use caution in elderly individuals due to increased risk of falls and cognitive impairment.
• Evaluate for depression, suicidal ideation, or other psychiatric conditions before initiating therapy.
• Counsel patients about potential next‑day impairment and advise against operating machinery or driving.

Halcion can interact with other medications, affecting its sedative properties or metabolism.

Avoid

• Concomitant use with other central nervous system depressants such as benzodiazepines, opioids, barbiturates, or alcohol.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin) that can increase triazolam levels.

Use with caution

• CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) which may reduce effectiveness.
• Antidepressants that lower seizure threshold.
• Antihistamines or antipsychotics that may enhance sedation.
• Herbal supplements like St. John’s wort that affect hepatic enzymes.
• Medications that prolong QT interval, requiring cardiac monitoring.